The U.S. Food and Drug Administration has approved a nose spray to help treat depression, Johnson & Johnson announced Tuesday ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

Researchers at Brigham and Women’s Hospital have developed a nasal spray that could provide broad-spectrum protection against ...